Biological Intellectual Property Protection Act of 2025

HR 6624, the Biological Intellectual Property Protection Act of 2025, requires export licenses for digital files representing human- or AI-designed synthetic DNA or RNA sequences when sent to foreign entities linked to countries designated as national security concerns (like China). It directly affects biotechnology companies and researchers exporting such digital sequence data, mandating licenses for these specific exports within one year of the law's enactment. The key mechanism is a new license requirement under export controls, targeting digital files that could reveal sensitive biotechnology research. This policy change aims to prevent foreign adversaries from accessing U.S. biotech intellectual property through synthetic biology data exports.